全甲状腺切除术后左甲状腺素剂量充足性:系统综述与荟萃分析
该系统综述与荟萃分析纳入11项研究共2577例全甲状腺切除术后患者,评估首次随访时甲状腺功能正常率。汇总率为33.9%,各给药策略间无显著差异,现有指南推荐的按体重给药方案可能不够充分。
要点
- 全甲状腺切除术后首次随访仅约三分之一患者达到甲状腺功能正常。
- 固定剂量、按体重给药及算法化方案间甲状腺功能正常率无显著差异。
- 指南推荐的按公斤体重给药方案可能不足以实现早期甲状腺功能正常。
核心结论
- 全甲状腺切除术后首次随访时甲状腺功能正常率仅约33.9%,与左甲状腺素给药策略无关。
- 现有指南推荐的按公斤体重给药方案可能不够充分,个性化算法结果也不一致。
研究设计与样本
- 系统综述与荟萃分析,纳入2000至2024年发表的11项研究,共2577例全甲状腺切除术后患者。
- 给药策略包括固定剂量、按体重给药和个体化算法方法,采用荟萃回归和亚组分析探索异质性。
主要发现
- 首次随访时汇总甲状腺功能正常率为33.9%,研究间异质性高(I2=82.68%)。
- 按体重给药组甲状腺功能正常率为29%,固定或算法组为40%,但无统计学显著性。
- 荟萃回归未发现任何有统计学意义的预测因子。
- 良性与恶性甲状腺疾病患者间、回顾性与前瞻性研究设计间均无显著差异。
关键数值与推荐
- 汇总甲状腺功能正常率33.9%(11项研究,2577例患者,I2=82.68%)。
- 按体重给药方案甲状腺功能正常率29%,固定或算法方案40%(无统计学显著性)。
临床怎么用
- 临床医生应知晓全甲状腺切除术后首次随访甲状腺功能正常率较低,需加强监测和剂量调整。
- 不应仅依赖指南推荐的按公斤体重给药方案,需考虑个体化因素并密切随访。
局限性
- 研究间异质性高(I2=82.68%),可能影响结果可靠性。
- 未识别出有统计学意义的预测因子,无法明确优化剂量的关键因素。
- 需未来前瞻性研究完善个体化给药方案并识别影响左甲状腺素需求的其他因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total thyroidectomy requires lifelong levothyroxine (LT4) therapy. Achieving optimal thyroid hormone replacement at the first postoperative follow-up might be harder than expected. Despite the various LT4 dose-choosing strategies tested, there is no consensus on the most effective approach to achieve early euthyroidism. MATERIALS AND METHODS: We performed a systematic review and meta-analysis, including studies published between 2000 and 2024 that reported the proportion of patients achieving euthyroidism at first follow-up after total thyroidectomy. Data from 11 studies comprising 2577 patients were analyzed. LT4 dosing strategies included fixed-dose, weight-based (dose/kg), and individualized algorithm-based methods. Meta-regression and subgroup analyses were used to explore sources of heterogeneity. RESULTS: The pooled euthyroidism rate at first follow-up was 33.9%, with high heterogeneity across studies (I2 = 82.68%). No dosing strategy consistently outperformed others: dose/kg methods achieved 29% euthyroidism, while fixed or algorithm-based approaches achieved 40%, though without statistical significance. Meta-regression analysis did not identify any statistically significant predictor. No significant differences emerged between patients treated for benign or malignant thyroid diseases or between retrospective and prospective study designs. CONCLUSION: Only about one-third of patients achieve euthyroidism at first follow-up after thyroidectomy, regardless of LT4 dosing strategy. The current guidelines recommendation of applying a pro/kg dose may not be adequate, and even personalized algorithms yield inconsistent results. Future prospective studies are needed to refine individualized dosing protocols and identify additional factors influencing LT4 requirements.
引用
- Chiardi I, Croce L, Caccavale P, et al. Establishing the Adequate Levothyroxine Dose After Total Thyroidectomy: A Systematic Review With Meta-analysis. J Clin Endocrinol Metab. 2025. PMID: 40682434. doi:10.1210/clinem/dgaf417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。